+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Dr Daisuke Nonaka
Thoracic pathology, lung cancer, mesotheliomas, thymic tumours, soft tissue sarcoma, skin cancer, endocrine pathology, thyroid disease, parathyroid cancer, gastrointestinal (GI) cancer, adrenal cancer, genitourinary pathology, head and neck pathology,
I specialise in oncological histopathology covering head and neck, endocrine, thoracic and genitourinary pathology, soft tissue sarcoma, skin tumours and metastatic tumours of unknown primary, including rare and unusual tumours. I have also worked for New York University Medical Center and Memorial Sloan-Kettering Cancer Center in the USA, and the National Cancer Institute, Milan, Italy. I am actively involved in research activities and have written more than 70 publications.
To Make an appointment, call HCA on +44(0)20 7079 4399
or click here
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2017 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.